Bausch & Lomb taps Schering-Plough execs as chairman, CEO

Bausch & Lomb announced this week that former Schering-Plough executives Fred Hassan and Brent Saunders were named chairman and CEO, respectively.

Bausch & Lomb announced this week that former Schering-Plough executives Fred Hassan and Brent Saunders named chairman and CEO, respectively. Both Hassan and Saunders left the pharmaceutical company following its merger with Merck.

Under CEO Saunders, the private eye care company will focus on three areas: contact lenses and solutions, prescription eye medicines and surgical equipment, and intraocular lenses. Bausch & Lomb faced reputation issues, following a recall for a lens solution that "was blamed for a flurry of potentially blinding fungal infections."

Matthew Herper at Forbes writes:

The job is a perfect fit. Bausch needs its manufacturing cleaned up and its brand marketing improved. Those have always been strengths for both Hassan and Saunders.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.